Kevin D. Boyd

Eastern Road
Brighton, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Prior anti-BCMA antibody-drug conjugate exposure does not impact long-term outcomes with subsequent anti-BCMA T-cell-engaging bispecific antibodies: a singlecenter real-world data analysis.

Prior anti-BCMA antibody-drug conjugate exposure does not impact long-term outcomes with subsequent anti-BCMA T-cell-engaging bispecific antibodies: a singlecenter real-world data analysis.

Journal: Haematologica

Published: June 06, 2026

AI derived Whole-Body MRI metrics in multiple myeloma patients reveal unique insights into body composition and outcomes.

AI derived Whole-Body MRI metrics in multiple myeloma patients reveal unique insights into body composition and outcomes.

Journal: Blood advances

Published: April 30, 2026

Clinical and immunological effects of adding cyclophosphamide to pomalidomide-dexamethasone in relapsed-refractory multiple myeloma: The randomized MUKseven trial.

Clinical and immunological effects of adding cyclophosphamide to pomalidomide-dexamethasone in relapsed-refractory multiple myeloma: The randomized MUKseven trial.

Journal: British journal of haematology

Published: October 02, 2025

Evaluating the Real-World Value of Daratumumab Addition to Multiple Myeloma Induction Therapy by Real-World Minimal Residual Disease Assessment and Extended Genetic Profiling.

Evaluating the Real-World Value of Daratumumab Addition to Multiple Myeloma Induction Therapy by Real-World Minimal Residual Disease Assessment and Extended Genetic Profiling.

Journal: Clinical lymphoma, myeloma & leukemia

Published: September 07, 2025

Targeted magnetic resonance imagings (MRIs) inform clinical management in biochemically stable multiple myeloma patients presenting with new pain.

Targeted magnetic resonance imagings (MRIs) inform clinical management in biochemically stable multiple myeloma patients presenting with new pain.

Journal: Clinical radiology

Published: June 20, 2025

Challenging the concept of functional high-risk myeloma through transcriptional and genetic profiling.

Challenging the concept of functional high-risk myeloma through transcriptional and genetic profiling.

Journal: Blood

Published: May 14, 2025

Whole body MRI by MY-RADS for imaging response assessment in multiple myeloma.

Whole body MRI by MY-RADS for imaging response assessment in multiple myeloma.

Journal: Blood cancer journal

Published: March 07, 2025

Factors associated with the development of gastrointestinal adverse events in dogs with multicentric lymphoma treated with CHOP or CEOP-based protocols: a multi-institutional, retrospective study.

Factors associated with the development of gastrointestinal adverse events in dogs with multicentric lymphoma treated with CHOP or CEOP-based protocols: a multi-institutional, retrospective study.

Journal: The Journal of small animal practice

Published: August 05, 2024

Management of relapsed multiple myeloma: A British Society of Haematology and UK Myeloma Society guideline.

Management of relapsed multiple myeloma: A British Society of Haematology and UK Myeloma Society guideline.

Journal: British journal of haematology

Published: July 25, 2024

Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial.

Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial.

Journal: The Lancet. Haematology

Published: June 21, 2024

Reversible carfilzomib-induced pulmonary arterial hypertension: don't take your eyes off the ball!

Reversible carfilzomib-induced pulmonary arterial hypertension: don't take your eyes off the ball!

Journal: The European respiratory journal

Published: June 04, 2024

The acceptability of using wearable electronic devices to monitor physical activity of patients with Multiple Myeloma undergoing treatment: a systematic review.

The acceptability of using wearable electronic devices to monitor physical activity of patients with Multiple Myeloma undergoing treatment: a systematic review.

Journal: Clinical hematology international

Published: May 03, 2024

Showing 1-12 of 47

Last Updated: 09/26/2026